Trade Summary

1 week ago, Derynck Mika K, serving as Dir at Enliven Therapeutics, Inc. (ELVN), sold 158,795 shares at $60.21 per share, for a total transaction value of $9,561,586.85.

This sale represents a 100.00% decrease in Derynck Mika K's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, August 4, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 7, 2026 (accepted Aug 6, 8:18 PM ET), 3 days after the trade was made.

Enliven Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.